Cargando…

Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report

BACKGROUND: Diabetic cardiomyopathy (DC) is defined as a ventricular diastolic and/or systolic dysfunction, which is directly related to diabetes mellitus (DM) in the absence of coronary artery disease, valvular, congenital or hypertensive heart disease, and alcoholism. In this report, we present an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocabaş, Umut, Yılmaz, Özgür, Kurtoğlu, Volkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601186/
https://www.ncbi.nlm.nih.gov/pubmed/31449603
http://dx.doi.org/10.1093/ehjcr/ytz049
_version_ 1783431256689606656
author Kocabaş, Umut
Yılmaz, Özgür
Kurtoğlu, Volkan
author_facet Kocabaş, Umut
Yılmaz, Özgür
Kurtoğlu, Volkan
author_sort Kocabaş, Umut
collection PubMed
description BACKGROUND: Diabetic cardiomyopathy (DC) is defined as a ventricular diastolic and/or systolic dysfunction, which is directly related to diabetes mellitus (DM) in the absence of coronary artery disease, valvular, congenital or hypertensive heart disease, and alcoholism. In this report, we present an unusual case of a patient with DC and reversible, acute left ventricular systolic dysfunction due to cardiotoxicity of hyperosmolar hyperglycaemic state (HHS). CASE SUMMARY: A 20-year-old male patient presented with weakness and polyuria. Physical examination and electrocardiogram were normal. Laboratory results and arterial blood gas analysis were consistent with HHS. Baseline echocardiography showed global left ventricular hypokinesis with an ejection fraction (EF) of 36%. The patient’s clinical condition improved after blood glucose level normalization and echocardiography revealed progressive improvement in the left ventricular systolic function with an EF of 54% at the 5-day follow-up and an EF of 69% at the 15-day follow-up. DISCUSSION: Uncontrolled DM and hyperglycaemic crisis may result in cardiotoxicity, acute left ventricular systolic dysfunction, and DC. The pathophysiological mechanism of this phenomenon is still unclear. Blood glucose control is the most important strategy for the prevention of DC.
format Online
Article
Text
id pubmed-6601186
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-66011862019-07-29 Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report Kocabaş, Umut Yılmaz, Özgür Kurtoğlu, Volkan Eur Heart J Case Rep Case Reports BACKGROUND: Diabetic cardiomyopathy (DC) is defined as a ventricular diastolic and/or systolic dysfunction, which is directly related to diabetes mellitus (DM) in the absence of coronary artery disease, valvular, congenital or hypertensive heart disease, and alcoholism. In this report, we present an unusual case of a patient with DC and reversible, acute left ventricular systolic dysfunction due to cardiotoxicity of hyperosmolar hyperglycaemic state (HHS). CASE SUMMARY: A 20-year-old male patient presented with weakness and polyuria. Physical examination and electrocardiogram were normal. Laboratory results and arterial blood gas analysis were consistent with HHS. Baseline echocardiography showed global left ventricular hypokinesis with an ejection fraction (EF) of 36%. The patient’s clinical condition improved after blood glucose level normalization and echocardiography revealed progressive improvement in the left ventricular systolic function with an EF of 54% at the 5-day follow-up and an EF of 69% at the 15-day follow-up. DISCUSSION: Uncontrolled DM and hyperglycaemic crisis may result in cardiotoxicity, acute left ventricular systolic dysfunction, and DC. The pathophysiological mechanism of this phenomenon is still unclear. Blood glucose control is the most important strategy for the prevention of DC. Oxford University Press 2019-04-25 /pmc/articles/PMC6601186/ /pubmed/31449603 http://dx.doi.org/10.1093/ehjcr/ytz049 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Reports
Kocabaş, Umut
Yılmaz, Özgür
Kurtoğlu, Volkan
Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report
title Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report
title_full Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report
title_fullStr Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report
title_full_unstemmed Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report
title_short Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report
title_sort diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601186/
https://www.ncbi.nlm.nih.gov/pubmed/31449603
http://dx.doi.org/10.1093/ehjcr/ytz049
work_keys_str_mv AT kocabasumut diabeticcardiomyopathyacuteandreversibleleftventricularsystolicdysfunctionduetocardiotoxicityofhyperglycaemichyperosmolarstateacasereport
AT yılmazozgur diabeticcardiomyopathyacuteandreversibleleftventricularsystolicdysfunctionduetocardiotoxicityofhyperglycaemichyperosmolarstateacasereport
AT kurtogluvolkan diabeticcardiomyopathyacuteandreversibleleftventricularsystolicdysfunctionduetocardiotoxicityofhyperglycaemichyperosmolarstateacasereport